Butterfly Network Receives FDA Clearance for AI-Enabled Lung Diagnostic Device

Digital health company, Butterfly Network, Inc., (NYSE: BFLY), has received 510(k) clearance for a groundbreaking AI-enabled device that may simplify how healthcare professionals evaluate patients with suspected diminished lung function.

Butterfly’s shares rose 22% in pre-market trading following the news this week.

Highlights

 Butterfly’s Auto B-line Counter is able to produce a B-line count from just a six second ultrasound clip, using deep learning technology.

B-lines appear on ultrasound scans as bright, vertical lines that indicate wetness in the lungs. They are associated with pulmonary air-space disease, such as congestive heart failure, chronic obstructive pulmonary disease, pneumonia and COVID-19.

Butterfly’s technology has the potential to deliver a more consistent interpretation of B-lines, potentially accelerating clinicians’ ability to make informed treatment decisions at the point of care.

The company’s Auto B-line Counter algorithm utilizes the state-of-the-art instant percent counting method that assigns numbers to confluent B-lines by the percentage of rib space occupied in addition to counting discrete B-lines.

 About Butterfly Network

Butterfly Network created the world’s first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. The company’s mission is to democratize medical imaging and contribute to the aspiration of global health equity, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip™ technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ can be purchased today by trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, North America and South America.

Share This Article

 

About the Author

Butterfly Network Receives FDA Clearance for AI-Enabled Lung Diagnostic Device

Editor Prism MarketView